@incollection{, A83F3CF72A42483B28E99E28D9BD6088 , author={{MarcelNogueira}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}2031520 } @incollection{b0, , title={{The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study}} , author={{ JDStanaway } and { ADFlaxman } and { MNaghavi } and { CFitzmaurice } and { TVos } and { IAbubakar }} , journal={{Lancet}} 388 , year={2013. 2016} } @incollection{b1, , title={{Strategies to C virus (HCV) infection disease burdenvolume}} , author={{ EGane } and { DKershenobich } and { CSeguin-Devaux } and { KristianPAho } and { I } and { Dalgard }} , journal={{Journal of viral hepatitis}} 2 1 , year={2015} , note={Suppl} } @incollection{b2, , title={{Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals}} , author={{ JChhatwal } and { XWang } and { TAyer } and { MKabiri } and { RTChung } and { CHur }} , journal={{Hepatology}} 64 , year={2016} } @book{b3, , title={{Combating Hepatitis B and C to Reach Eliminationby 2030. World Health Organization}} , year={2016} } @incollection{b4, , title={{The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C}} , author={{ BMaasoumy } and { KPort } and { CalleSerrano } and { BMarkova } and { AASollik } and { LManns } and { MP }} , journal={{Alimentary pharmacology & therapeutics}} 38 , year={2013} } @book{b5, , title={{Guideline for management and treatment of chronic hepatitis C and co-infections}} , author={{ Brasil }} , publisher={Brazilian} , address={Brasília} , note={Protocolo Clínico e Diretrizes Terapêuticas para o tratamento da hepatite viral crônica C e co-infecções} } @book{b6, , title={{Ministry of Health}} , year={2017} , note={Ministério da Saúde do Brasil} } @book{b7, , title={{HEP Drug Interactions}} , author={{ LiverpoolUo }} , year={2017} } @incollection{b8, , title={{EASL Recommendations on Treatment of Hepatitis C}} , journal={{Journal of hepatology}} , year={2018. 2018} } @incollection{b9, , title={{Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations}} , author={{ CTDe Kanter } and { JPDrenth } and { JEArends } and { HWReesink } and { MVan Der Valk } and { RJDe Knegt }} , journal={{Clinical pharmacokinetics}} 53 , year={2014} } @incollection{b10, , title={{Single-dose pharmacokinetics and safety of daclatasvir in subjects with renal function impairment}} , author={{ TGarimella } and { RWang } and { WLLuo } and { CHwang } and { DSherman } and { HKandoussi }} , journal={{Antiviral therapy}} 20 , year={2015} } @incollection{b11, , title={{Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole}} , author={{ TSaussele } and { OBurk } and { JKBlievernicht } and { KKlein } and { ANussler } and { NNussler }} , journal={{Clinical pharmacology and therapeutics}} 82 , year={2007} } @incollection{b12, , title={{Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution}} , author={{ TPGauthier } and { EMoreira } and { CChan } and { ACabrera } and { MToro } and { MZCarrasquillo }} , journal={{Journal of the American Pharmacists Association}} 56 , year={2016} , note={JAPhA} } @book{b13, , title={{Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B. Infectious diseases and therapy}} , author={{ RMAbreu } and { CDa Silva Ferreira } and { ASFerreira } and { ERemor } and { PDNasser } and { FJCarrilho }} , year={2016} 5 } @incollection{b14, , title={{Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions}} , author={{ JALangness } and { MNguyen } and { AWieland } and { GTEverson } and { JJKiser }} , journal={{World J Gastroenterol}} 23 , year={2017} } @incollection{b15, , title={{Effects of a Telephone Counselling Intervention by Pharmacist (TelCIP) on medication adherence, patient beliefs and satisfaction with information for patients starting treatment: study protocol for a cluster randomized controlled trial}} , author={{ MJKooy } and { EcgVan Geffen } and { ERHeerdink } and { LVan Dijk } and { MLBouvy }} , journal={{BMC Health Serv Res}} 219 , year={2014} } @book{b16, , title={{Incidence of Drug Interactions Identified by Clinical Pharmacists in Veterans Initiating Treatment for Chronic Hepatitis C Infection. The Annals of pharmacotherapy}} , author={{ AAOttman } and { MLTownsend } and { MGHashem } and { VPDimondi } and { RBBritt }} , year={2018} 1060028018766507 } @incollection{b17, , title={{Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses}} , author={{ FFaul } and { EErdfelder } and { ABuchner } and { AGLang }} , journal={{Behav Res Methods}} 41 , year={2009} } @incollection{b18, , title={{Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil}} , author={{ HCheinquer } and { HSette } and { JrWolff } and { FHDe Araujo } and { ACoelho-Borges } and { SSoares } and { Srp }} , journal={{Annals of hepatology}} 16 , year={2017} } @book{b19, , title={{Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil. The Brazilian journal of infectious diseases: an official publication of the}} , author={{ VLFerreira } and { HhlBorba } and { AWiens } and { MlaPedroso } and { VfcRadunz } and { CapIvantes }} , year={2018} , publisher={Brazilian Society of Infectious Diseases} } @incollection{b20, , title={{Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection}} , author={{ MSSulkowski } and { DFGardiner } and { MRodriguez-Torres } and { KRReddy } and { THassanein } and { IJacobson }} , journal={{The New England journal of medicine}} 370 , year={2014} } @incollection{b21, , title={{The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions}} , author={{ EJSmolders } and { FABerden } and { CTDe Kanter } and { WKievit } and { JPDrenth } and { DMBurger }} , journal={{United European Gastroenterol J}} 5 , year={2017} } @incollection{b22, , title={{Prevalence of selfmedication in Brazil and associated factors}} , author={{ PSArrais } and { MEFernandes } and { TDPizzol } and { LRRamos } and { SSMengue } and { VLLuiza }} , journal={{Revista de saude publica}} 50 13 , year={2016} }